Atlas Trials

Study to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male Participants

Clinical trial NCT07726914 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07726914
Sponsor
Sanofi
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Graft Versus Host Disease
Start date
2026-08-06
Primary completion
2026-09-28
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.